Samsung announced today that it entered into a supply contract with Lunit to utilize its AI-powered solutions for chest screenings. Boston Imaging, the U.S. headquarters of Samsung’s digital radiography and ultrasound business, inked the deal. Lunit offers AI technology for cancer diagnostics and therapeutics. Together, they aim to enable faster and more accurate chest screenings […]
Lunit
Study backs Lunit’s AI-powered cancer diagnostics
Lunit recently announced the results of its study demonstrating the effectiveness of artificial intelligence (AI) solutions in cancer diagnostics. The study, published in the journal Radiology, explored the impact of medical AI solutions’ accuracy on radiologists’ diagnostic determination. It used Lunit’s Insight CXR AI solution for chest X-ray analysis and showed that AI could improve […]
Lunit wins CE Mark for AI-based breast cancer detection software
Lunit announced today that it received CE Mark approval in Europe for its Lunit Insight MMG artificial intelligence-based software. Insight MMG uses AI to analyze mammography images and provide the location of lesions that are suspicious for breast cancer, along with an abnormality score that reflects the probability of the existence of detected lesions. According […]
Lunit wins CE Mark for AI-powered chest X-ray software
Medical artificial intelligence company Lunit announced that it won CE Mark approval for its Lunit Insight CXR up-to-date chest X-ray analysis AI. The Seoul-based company said its Lunit Insight CXR is designed to help increase accuracy for detecting more findings and alleviate the burden on radiologists who conduct routine chest X-ray procedures. Lunit Insight CXR […]